Hillsdale Investment Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10
Closed -$2.85K 663
2023
Q2
$2.85K Sell
10
-2,890
-100% -$803K ﹤0.01% 530
2023
Q1
$629K Hold
2,900
0.05% 264
2022
Q4
$596K Sell
2,900
-300
-9% -$75.9K 0.05% 282
2022
Q3
$890K Sell
3,200
-1,500
-32% -$381K 0.08% 173
2022
Q2
$898K Sell
4,700
-1,000
-18% -$177K 0.07% 192
2022
Q1
$1.18M Hold
5,700
0.08% 186
2021
Q4
$1.02M Hold
5,700
0.07% 247
2021
Q3
$1.17M Sell
5,700
-1,000
-15% -$196K 0.09% 190
2021
Q2
$1.27M Buy
+6,700
New +$1.1M 0.1% 185

Other funds holding SWAV

Hillsdale Investment Management's SWAV Position: Q3 2023 in Review

Hillsdale Investment Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2023, closing a stake of 10 shares — an estimated $2.85K sold.

Hillsdale Investment Management first reported a position in SWAV in Q2 2021 and held it in 9 quarters. The position peaked at $1.27M in Q2 2021. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

  • Hillsdale Investment Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Hillsdale Investment Management sold 10 Shockwave Medical, Inc. Common Stock shares in Q3 2023, an estimated $2.85K.
  • Hillsdale Investment Management first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2021 and held it in 9 quarters.
  • Hillsdale Investment Management's Shockwave Medical, Inc. Common Stock position peaked at $1.27M in Q2 2021.
  • 412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2023.

Based on Hillsdale Investment Management's 13F filing for Q3 2023, filed 9 Nov 2023.